Label: ANTHELCIDE EQ- oxibendazole paste

  • Category: OTC ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Animal Drug Application

Drug Label Information

Updated March 27, 2020

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    HORSE DEWORMER

    For use in horses only

  • DESCRIPTION

    Anthelcide EQ Paste is a paste formulation of oxibendazole, a broad-spectrum benzimidazole anthelmintic. This formulation has been developed for ease of administration. Each syringe contains 0.85 oz (24 g) of paste.

     Anthelcide EQ Paste contains:
     Oxibendazole 22.7%
  • INDICATIONS

    Anthelcide EQ Paste is indicated for removal and control of: large strongyles (Strongylus edentatus, S. equinus, S. vulgaris); small strongyles (species of the genera Cylicostephanus, Cylicocyclus, Cyathostomum, Triodontophorus, Cylicodontophorus, and Gyalocephalus); large roundworms (Parascaris equorum); pinworms (Oxyuris equi) including various larval stages; and threadworms (Strongyloides westeri).

  • CONTRAINDICATIONS

    Anthelcide EQ is contraindicated in severely debilitated horses or horses suffering from infectious disease, toxemia, or colic.

  • Warning

      Do not use in horses intended for human consumption.

  • PRECAUTIONS

    Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

    Keep Out of Reach of Children.

  • OTHER WARNINGS

    Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method). A decrease in a drug’s effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.

  • DOSAGE AND ADMINISTRATION

    The dosage of oxibendazole is 10 mg/kg (2.2 lb) of body weight (15 mg/kg for strongyloides). Each mark on the syringe delivers Anthelcide EQ to treat 100 lb (67 lb for strongyloides). Horses maintained on premises where reinfection is likely to occur should be retreated in 6–8 weeks.

    Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.

    Dosage Table
    10 mg/kg 15 mg/kg
    Syringe Mark Horse Weight (lb) Syringe Mark Horse Weight (lb)
     100 100 300 200
     200 200 600 400
     400 400 900 600
     600 600 1200 800
     800 800  
     1000 1000  
     1200 1200  

    Anthelcide EQ is compatible with carbon disulfide, which can be used concurrently for bot control (Gasterophilus spp.) when administered by a veterinarian. Routine carbon disulfide cautions must be observed.

    USE OF SYRINGE

    Determine the weight of the horse and dial the correct setting on the plunger, having the side of the wheel nearest the barrel on the desired mark. Remove the cap from the syringe. Insert the tip of the syringe into the side of the animal's mouth between the incisor and molar teeth and press the plunger down as far as it will go, depositing the paste on the back of the tongue.

  • HOW SUPPLIED

    Anthelcide EQ paste is supplied in 0.85-oz (24-g) syringes.

  • STORAGE

    Store at controlled room temperature 15°–30°C (59°–86°F).

  • SPL UNCLASSIFIED SECTION

    Approved by FDA under NADA # 121-042

    zoetis

    Distributed by:
    Zoetis Inc.
    Kalamazoo, MI 49007

    40028048
    Revised: June 2019

  • PRINCIPAL DISPLAY PANEL - 24 g Syringe Label

    24 g Syringe Label
  • INGREDIENTS AND APPEARANCE
    ANTHELCIDE EQ 
    oxibendazole paste
    Product Information
    Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:54771-6045
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OXIBENDAZOLE (UNII: 022N12KJ0X) (OXIBENDAZOLE - UNII:022N12KJ0X) OXIBENDAZOLE227 mg  in 1 g
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:54771-6045-224 g in 1 SYRINGE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NADANADA12104210/16/1981
    Labeler - Zoetis Inc. (828851555)